Analysts' Actions: Allergan, Broadcom, Clovis, Centene, Devon Energy

NEW YORK (TheStreet) -- RATINGS CHANGES

Allergan (AGN) was downgraded at Credit Suisse to neutral from outperform. Twelve-month price target is $190. Risk/reward is balanced, following the latest bid from Valeant (VRX), Credit Suisse said.

Big Lots (BIG) was downgraded to hold at TheStreet Ratings.

Broadcom (BRCM) was downgraded at Stifel to hold from buy, Stifel Nicolaus said. Valuation call, based on a 12-month price target of $35, Stifel Nicolaus said.

Broadcom was upgraded at Wedbush to outperform from neutral. Twelve-month price target is $43. Company is looking to sell or wind down the cellular baseband business, which has been an overhang, Wedbush said.

Chico's FAS (CHS) was downgraded to hold at TheStreet Ratings.

Clovis (CLVS) was downgraded at Citigroup to neutral. Twelve-month price target is $53. Company could face increased competition from AstraZeneca (AZN), Citi said.

Centene (CNC) was downgraded at Citigroup to sell. Takeover rumors will likely fizzle out, Citi said.

Devon Energy (DVN) was upgraded at Wells Fargo to outperform from market perform. Production visibility is improving, Wells Fargo said.

Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.


WATCH: More market update videos on TheStreet TV | More videos from Ruben Ramirez

Follow TheStreet on Twitter and become a fan on Facebook.

>>Read More: Banks Face Serious Threat in the Second Half

>>Read More: Greenberg: Apple's Latest Ad-Stravaganza

This article was written by a staff member of TheStreet.

More from Stocks

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Podcast: What TheStreet's Interns Learned From Jim Cramer and Action Alerts PLUS

Bank of America, Tariffs and the Goldman Sachs CEO Change: Jim Cramer Rewind

Bank of America, Tariffs and the Goldman Sachs CEO Change: Jim Cramer Rewind

Goldman Sachs Really Doesn't Like Apple's Stock

Goldman Sachs Really Doesn't Like Apple's Stock

Lee Munson on the Market, Trade and the Possibility of a Recession

Lee Munson on the Market, Trade and the Possibility of a Recession

Buy These 3 Killer Tech Stocks, Says Wall Street's #1 Analyst

Buy These 3 Killer Tech Stocks, Says Wall Street's #1 Analyst